Mode
Text Size
Log in / Sign up

Renal failure

Part of Kidney Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for renal failure

26 trials tracked for renal failure: 12 in phase 3 or 4 and 2 with published results. The most-cited published study has 86 citations.

26Trials tracked
12Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 11 Phase 2 5 Other / NA 9
  1. Phase 3 Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily. Completed · 86 cited
  2. Phase 3 Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis Completed · 13 cited
  3. Phase 4 Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant Completed
  4. Phase 3 A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis Completed
  5. Phase 3 AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD) Completed
  6. Phase 3 Pharmacokinetic Comparison Of All FK-506 Formulations Completed
Show 20 more trials
  1. Phase 3 Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure Completed
  2. Phase 3 Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO) Completed
  3. Phase 3 Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy Completed
  4. Phase 3 GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis Completed
  5. Phase 3 Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily Completed
  6. Phase 3 Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx Completed
  7. Phase 2 Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients Completed
  8. Phase 2 Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant Completed
  9. Phase 2 Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis Completed
  10. Phase 2 Does Nesiritide Provide Renal Protection Completed
  11. Phase 2 Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients Completed
  12. N/A VasQ External Support for Arteriovenous Fistula Completed
  13. N/A Comparing Everolimus and Sirolimus in Renal Transplant Recipients Completed
  14. N/A Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis Completed
  15. N/A The Prevention of Failure to Rescue Using Early Warning Scoring Completed
  16. N/A Improving Patient Prioritization During Hospital-homecare Transition Completed
  17. N/A Metabolites of Tramadol in the Postoperative Surgical Patients Completed
  18. N/A Quanta Home Run Trial Completed
  19. N/A Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes Completed
  20. N/A Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation. Completed

Showing the 26 most-cited and recently-updated of 26 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Renal failure: what the trials found

Management of renal failure involves several pharmacological and procedural interventions. For patients requiring transplant, LCP-Tacro has been evaluated for efficacy; one study reported a low composite endpoint for efficacy failure within 12 months 7. Additionally, switching from Prograf to LCP-Tacro in stable kidney transplant patients was associated with a significant reduction in hand tremors (p=0.0048) 9.

Prograf (tacrolimus) has been studied extensively for transplant outcomes; data showed no statistically significant difference in treatment failures at 12 months (p=0.999) or 24 months (p=0.835) across compared groups 8. Other pharmacological interventions include the use of sodium bicarbonate 12, ferric citrate 5, and Heme Iron Polypeptide (Proferrin), which showed stable hemoglobin concentrations at 6 months 11.

Cardiovascular and metabolic management in renal patients includes the use of 10mg Rosuvastatin 13. For vascular access, the GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface demonstrated significantly higher target lesion primary patency at 6, 12, and 24 months compared to standard alternatives (p=0.008) 10.

Alternative surgical materials such as Human Acellular Vessel (HAV) have been evaluated in phase 3 trials for renal-related applications 4.

Recent results — preliminary, needs further review

  • VasQ was investigated in a recent trial 1.
  • The PREVENT clinical decision support tool was evaluated regarding rehospitalizations within 60 days after hospital discharge 19.

For the clinician treating this condition

  • LCP-Tacro may be an effective alternative to Prograf for managing hand tremors in stable kidney transplant patients.
  • GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface shows superior patency rates over 24 months compared to standard options.
  • Standard interventions such as Rosuvastatin, sodium bicarbonate, and ferric citrate are established components of management.

AI synthesis of 11 cited trials, updated Jun 24, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Kidney Diseases

Related studies from across the Kidney Diseases family.

Programmed cell death pathways form a spatiotemporally regulated network driving tubular damage in renal IRI
Allergy & Immunology Sys. Review
Programmed cell death pathways form a spatiotemporally regulated network driving tubular damage in renal IRI New research identifies key pathways driving acute kidney injury
This systematic review examines the roles of pyroptosis, ferroptosis, cuproptosis, and necroptosis as key mediators of inflammation and oxid…
Researchers have mapped out a complex network of cell death pathways that drive inflammation and damage in patients with acute kidney injury…
Fluoroless ultrasound-guided techniques lower complications in percutaneous nephrolithotomy with equivalent stone-free rates
Urology Meta-analysis
Fluoroless ultrasound-guided techniques lower complications in percutaneous nephrolithotomy with equivalent stone-free rates Fluoroless ultrasound guidance reduces complications during kidney stone surgery
This systematic review and meta-analysis of randomized studies evaluated fluoroless ultrasound-guided versus fluoroscopy-guided techniques f…
A meta-analysis of randomized trials shows that using ultrasound instead of X-ray guidance lowers overall complications for kidney stone rem…
Meta-analysis of RCTs shows mPCNL yields higher single-session stone-free rates than RIRS for medium renal stones
Urology Meta-analysis
Meta-analysis of RCTs shows mPCNL yields higher single-session stone-free rates than RIRS for medium renal stones Mini-PCNL clears kidney stones better than RIRS in one session
This meta-analysis of randomized controlled trials evaluated retrograde intrarenal surgery versus miniaturized percutaneous nephrolithotomy …
Mini-PCNL clears medium-sized kidney stones in one session more often than RIRS, but RIRS has fewer complications and shorter hospital stays…
Narrative review on anthracycline cardiorenal toxicity and dexrazoxane protection
Cardiology Sys. Review
Narrative review on anthracycline cardiorenal toxicity and dexrazoxane protection Doctors seek better ways to protect heart and kidney health during cancer drug treatment
This narrative review synthesizes evidence on anthracycline-induced cardiorenal toxicity and dexrazoxane's protective role. The authors note…
Cancer treatments called anthracyclines can harm the heart and kidneys. This review explains why doctors need new strategies to keep patient…
Narrative review discusses exosomes for renal ischemia-reperfusion injury management and translational barriers
Drug Pipeline Sys. Review
Narrative review discusses exosomes for renal ischemia-reperfusion injury management and translational barriers Tiny Kidney Protectors May Shield Patients From Sudden Damage
This narrative review examines the potential of exosomes for managing renal ischemia-reperfusion injury. The authors discuss the scope of th…
• Exosomes might prevent kidney harm when blood flow returns • Helps surgery patients and trauma survivors avoid kidney failure • Still in l…
Narrative review on renal involvement in primary Sjögren's disease and therapeutic prospects
Allergy & Immunology Sys. Review
Narrative review on renal involvement in primary Sjögren's disease and therapeutic prospects Understanding kidney problems in primary Sjogren's disease patients needs more research
This narrative review synthesizes current knowledge on renal involvement in primary Sjögren's disease. It highlights that the pathogenic bas…
Doctors are still learning how kidneys get hurt in primary Sjogren's disease. Current treatments work by guesswork because the exact cause i…
Narrative review offers theoretical basis for selecting biologic therapies in psoriasis patients with renal concerns
Dermatology Sys. Review
Narrative review offers theoretical basis for selecting biologic therapies in psoriasis patients with renal concerns New Psoriasis Treatments May Protect Kidneys While Fighting Skin Flares
This narrative review examines the use of TNF-alpha, IL-17, and IL-12/23 inhibitors in psoriasis patients with renal concerns. The authors p…
• Some biologics shield kidneys from damage during psoriasis treatment • Helps the 8 million Americans with psoriasis and kidney worries • N…
Patient-specific 3D printed kidney models improved comprehension and satisfaction compared to conventional 2D CT scans in PCNL patients
Urology RCT
Patient-specific 3D printed kidney models improved comprehension and satisfaction compared to conventional 2D CT scans in PCNL patients 3D kidney models improve patient understanding before surgery
This randomized clinical study enrolled 40 individuals aged 18 to 80 planned for PCNL surgery.
A small study found that 3D printed kidney models significantly improved patient comprehension and satisfaction compared to standard 2D scan…
Surgical treatment for gouty tophi wounds associated with high healing rates in retrospective study
Orthopedics & Sports Medicine Cohort
Surgical treatment for gouty tophi wounds associated with high healing rates in retrospective study Surgery may help heal gouty tophi wounds
This retrospective cohort study of 130 patients with gouty tophi wounds in China observed high wound healing rates following surgical interv…
A small study shows that surgical treatment, including wound cleaning and vacuum drainage, helped most patients with gouty tophi wounds heal…
Retrospective cohort study links PPI use to drug-related problems in hospitalized renal disease patients
Drug Pipeline Cohort
Retrospective cohort study links PPI use to drug-related problems in hospitalized renal disease patients Nearly half of hospitalized kidney patients had drug problems linked to stomach acid reducers
This retrospective cohort study evaluated 520 hospitalized internal nephrology inpatients to assess drug-related problems (DRPs) associated …
Nearly half of hospitalized kidney patients faced drug problems linked to stomach acid reducers. Other medicines and dialysis types also rai…
Narrative review discusses renal risks in inflammatory bowel disease patients
Nephrology Sys. Review
Narrative review discusses renal risks in inflammatory bowel disease patients Kidney risks for people with inflammatory bowel disease remain unclear and need more study
This narrative review examines renal complications in individuals with inflammatory bowel disease.
People with inflammatory bowel disease face kidney risks, but current evidence relies on animal studies and lacks human proof.
VitoCheck EIT platform predicts standard diagnostics for cardiopulmonary and metabolic diseases
Radiology & Imaging Cohort
VitoCheck EIT platform predicts standard diagnostics for cardiopulmonary and metabolic diseases A new device predicts heart and lung health without needing a specialist
This cohort study in community settings evaluated a compact EIT platform for predicting standard diagnostic metrics.
A compact device accurately predicts standard heart and lung tests, helping bring better care to remote and community settings.